Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Alberto Papi, Bradley E. Chipps, Richard Beasley, Reynold A. Panettieri, Elliot Israel, Mark Cooper, Lynn Dunsire, Allison Jeynes-Ellis, Robert Rees, Frank C. Albers, Christy Cappelletti

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

Original languageEnglish (US)
JournalTherapeutic Advances in Respiratory Disease
Volume18
DOIs
StatePublished - Jan 1 2024
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study'. Together they form a unique fingerprint.

Cite this